SUZHOU,China,Feb. 13,2025-- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-306) of anti-HER2 bi
SINGAPORE,Feb. 13,2025-- Cloud4C,a global leader in AI-driven cloud and cybersecurity services,has achieved two prestigious AI specializations on Microsoft Azure: \'AI Platform on Microsoft Azure\' an
SEOUL,South Korea,Feb. 13,2025-- DAAN Biotherapeutics,a leading innovative drug development company specializing in T-cell receptor (TCR)- based therapies,has signed an exclusive licensing agreement w
On average,APAC leaders are struggling more with data management issues compared to North America/EMEA counterparts,according to global study from SoftServe
Databricks announces new product natively integrated into the SAP Business Data Cloud SAN FRANCISCO,Feb. 13,2025--Databricks,the Data and AI company,today announced the launch of SAP Databricks,a str
Landmark Collaboration Redefines Enterprise Data Management and Unleashes the Full Potential of Agentic AI
